Barclays PLC Increases Stock Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Barclays PLC boosted its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 342.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 53,439 shares of the company’s stock after buying an additional 41,358 shares during the period. Barclays PLC owned approximately 0.14% of Viemed Healthcare worth $392,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. National Bank of Canada FI boosted its position in shares of Viemed Healthcare by 91.2% during the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after buying an additional 1,596 shares during the period. Perkins Coie Trust Co purchased a new position in Viemed Healthcare during the 3rd quarter valued at $73,000. PDT Partners LLC bought a new position in Viemed Healthcare in the 3rd quarter valued at $78,000. Victory Capital Management Inc. increased its stake in Viemed Healthcare by 21.1% in the second quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after purchasing an additional 2,226 shares during the period. Finally, Walleye Capital LLC bought a new stake in shares of Viemed Healthcare during the third quarter worth $87,000. 74.24% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total transaction of $336,502.08. Following the transaction, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. This trade represents a 25.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nitin Kaushal sold 30,000 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $9.56, for a total transaction of $286,800.00. Following the completion of the transaction, the director now directly owns 126,843 shares of the company’s stock, valued at $1,212,619.08. This trade represents a 19.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 72,256 shares of company stock valued at $674,739 over the last quarter. 20.00% of the stock is owned by corporate insiders.

Viemed Healthcare Trading Down 0.2 %

NASDAQ VMD opened at $8.15 on Friday. The stock has a market cap of $317.36 million, a PE ratio of 30.19 and a beta of 1.47. Viemed Healthcare, Inc. has a 12 month low of $6.21 and a 12 month high of $10.44. The company’s 50-day moving average price is $8.44 and its 200-day moving average price is $7.94. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. The company had revenue of $58.00 million during the quarter. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.